Activated SALL4 enhances spheroid formation, invasion capacities, and key characteristics of cancer stem cells while upregulating the EMT markers, hepatic stem cell markers KRT19, EpCAM, and CD44, in hepatocyte cell lines. This evidence concerns the gene SALL4 and cancer.